Cellular distribution and phototoxicity of Benzoporphyrin derivative and Photofrin

Research in Experimental Medicine

Volumn 199, Issue 6, 1999, Pages 341-357

  Rousset, Nathalie ^a   Vonarx, Véronique ^a   Eléouet, Sabine ^a   Carré, Jérôme ^a   Bourré, Ludovic ^a   Lajat, Youenn ^a   Patrice, Thierry ^a  

^a Laboratoire de Photobiologie des Cancers   (France)

Author keywords

Adenocarcinoma cells; Benzoporphyrin derivative monoacid ring a; Photodynamic therapy; Photofrin

Indexed keywords

BENZOPORPHYRIN DERIVATIVE; PHOTOFRIN;

ARTICLE; CELLULAR DISTRIBUTION; COLON CANCER; DOSE RESPONSE; DRUG UPTAKE; FLUORESCENCE; HUMAN; HUMAN CELL; MICROFLUOROMETRY; PHOTODYNAMIC THERAPY; PHOTOTOXICITY; PRIORITY JOURNAL;

ADENOCARCINOMA; ANIMALS; ANTINEOPLASTIC AGENTS; CELL NUCLEUS; COLONIC NEOPLASMS; DIHEMATOPORPHYRIN ETHER; IMAGE PROCESSING, COMPUTER-ASSISTED; MICROSCOPY, CONFOCAL; MICROSCOPY, FLUORESCENCE; PHOTOSENSITIZING AGENTS; PHOTOTHERAPY; PORPHYRINS; RATS; RATS, INBRED STRAINS; TUMOR CELLS, CULTURED;

EID: 0033936652     PISSN: 03009130     EISSN: None     Source Type: Journal    
DOI: 10.1007/s004339900044     Document Type: Article

References (31)

1. 1. Aveline B, Hasan T, Redmond RW (1994) Photophysical properties and photosensitizing properties of benzoporphyrin derivative monoacid ring A (BPD-MA). Photochem Photobiol 59: 328-335
2. 2. Biel MA (1994) Photodynamic therapy and the treatment of neoplasic and non neoplasic of the larynx. Laryngoscope 104: 399-403
3. 3. Blais J, Amirand C, Ballini JP, Debey P, Foultier MT, Patrice T (1995) Photofrin-induced fluorescence in progressive and regressive murine colonic cancers cells: correlation with cell photosensitivity. J Photochem Photobiol B 27: 225-231
4. 4. Foultier MT, Vonarx-Coinsmann V, Cordel S, Combre A, Patrice T (1994) Modulation of colonic cancer adhesiveness by haematoporphyrin derivative therapy. J Photochem Photobiol B 23: 9-17
5. 5. Foultier MT, Vonarx-Coinsmann V, Xavier de Brito L, Morlet L, Robillard N, Patrice T (1994) DNA or cell kinetics flow cytometry analysis of 33 small gastrointestinal cancers treated by photodynamic therapy. Cancer 73: 1595-1607
6. 6. Gomer CJ (1989) Photodynamic therapy in the treatment of malignancies. Semin Hematol 26: 27-34
7. 7. Gomer CJ, Rucker NR, Ferraris A, Murphree AL (1986) Expression of potentially lethal damage in Chinese hamster cells exposed to hematoporphyrin derivative photodynamic therapy. Cancer Res 46: 3348-3352
8. 8. Jiang F, Lilge L, Logie B, Li Y, Chopp M (1997) Photodynamic therapy of 9L gliosarcoma with liposome-delivered photofrin. Photochem Photobiol 65: 701-706
9. 9. Jiang F, Lilge L, Grenier J, Wilson MD, Chopp M (1998) Photodynamic therapy of U87 human glioma in nude rat using liposome-delivered photofrin. Lasers Surg Med 22: 74-80
10. 10. Jocham D, Baumgarter R, Stepp H, Unsold E (1990) Clinical experience with the integral photodynamic therapy of bladder carcinoma. J Photochem Photobiol B 6: 183-187
11. 11. Kasbouai L, Harb J, Bernard S, Meflah K (1989) Difference in glycosylation state of fibronectin from two rat colon adenocarcinoma cell lines in relation to tumoral progressiveness. Cancer Res 49: 5317-5322
12. 12. Kessel D (1986) Sites of photosensitization by derivatives of hematoporphyrin. Photochem Photobiol 44: 489-494
13. 13. Kessel D, Dougherty J (1999) Agents used in photodynamic therapy. Rev Contemp Pharmacother 10: 19-24
14. 14. Kripke ML, Gruys E, Fidler IJ (1978) Metastatic heterogeneity of cells from an ultra-violet light induce murine fibrosarcoma of recent origin. Cancer Res 38: 2962-2967
15. 15. Lui H, Anderson RR (1993) Photodynamic therapy in dermatology: recent developments. Dermatol Clin 11: 1-13
16. 16. Malik Z, Djaldetti M (1980) Destruction of erythroleukemia, myelocytic leukemia and Burkitt lymphoma cells by photoactivated protoporphyrin. Int J Cancer 26: 495-500
17. 17. Marcus J, Glassberg G, Dimino-Emme L, Yamamoto R, Moy RL, Vari SG, Papaioannou T, Pergadia VR, Snyder WJ, Grundfest WS (1994) Photodynamic therapy for the treatment of squamous cell carcinoma using benzoporphyrin derivative. J Dermatol Surg Oncol 20: 375-82
18. 18. Martin F, Caignard A, Jeannin JF, Leclerc A, Martin M (1983) Selection by trypsin of two sublines of rat colon cancer forming progressive or regressive tumors. Int J Cancer 32: 623-627
19. 19. Masutani M, Richter AM, Dolphin D, Levy J, Horie T (1995) In vitro evaluation of benzoporphyrin derivatives using cultured cancer cells for photodynamic therapy. Nihon Univ J Med 37: 203-214
20. 20. Moan J (1986) Prophyrin-sensitized photodynamic inactivation of cells. Lasers Med Sci 1: 5-12
21. 21. Mosmann T (1983) Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxic assay. J Immunol Methods 65: 55-63
22. 22. Paget S (1989)The distribution of secondary growths in cancer of the breast. Lancet 1: 571-573
23. 23. Richter AM, Kelly B, Chow J, Lui DJ, Towers GJN, Dolphin D, Levy JG (1987) Preliminary studies on a more effective photoxic agent than hematoporphyrin. J Natl Cancer Inst 79: 1327-1332
24. 24. Richter AM, Waterfield E, Jain AK, Sternberg ED, Dolphin D, Levy JG (1990) In vitro evaluation of phototoxic properties of four structurally related benzoporphyrin derivatives. Photochem Photobiol 52: 495-500
25. 25. Richter AM, Meadows H, Jain AK, Canaan AJ, Levy JG (1994) Kinetics of cellular uptake and retention of the benzoporphyrin derivative (BPD), relevance to photodynamic therapy. SPIE Proceedings, Photodynamic Therapy of Cancer II 2325: 189-197
26. 26. Roberts DJH, Cairnduff F (1995) Photodynamic therapy of primary skin cancer: a review. Br J Plast Surg 48: 360-370
27. 27. Schneckenburger H, Ruck A, Bartos B, Steiner R (1988) Intracellular distribution of photosensitizing porphyrins measured by video-enhanced fluorescence microscopy. J Photochem Photobiol B 2: 355-363
28. 28. Smith GJ (1985) The effects of aggregation on the fluorescence and the triplet yield of hematoporphyrin. Photochem Photobiol 41: 123-126
29. 29. Vonarx V, Foultier MT, Xavier de Brito L, Anasagasti L, Morlet L, Patrice T (1995) Photodynamic therapy decreased cancer colonic adhesiveness and metastatic potential. Res Exp Med 195: 101-116
30. 30. Waterfield EM, Renke ME, Smits CB, Gervais MD, Bower RD, Stonefield MS, Levy G (1994) Wavelength-dependent effects of benzoporphyrin derivative monoacid ring A in vivo and in vitro. Photochem Photobiol 60: 383-387
31. 31. Weiss L, Ward PM (1983)Cell detachment and metastasis. Cancer Metastasis Rev 2: 111-127